

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * sarcomere organization (GO:0045214) | 9.23670129 |
| 2 | muscle filament sliding (GO:0030049) | 9.02074380 |
| 3 | actin-myosin filament sliding (GO:0033275) | 9.02074380 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.49311310 |
| 5 | myofibril assembly (GO:0030239) | 8.06398523 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.88428108 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.48426018 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 7.44044916 |
| 9 | plasma membrane repair (GO:0001778) | 7.03516558 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.03127060 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.00797621 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.75714127 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.57344259 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.32354458 |
| 15 | * cardiac muscle cell development (GO:0055013) | 6.00932587 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.99758636 |
| 17 | striated muscle contraction (GO:0006941) | 5.98072263 |
| 18 | * actomyosin structure organization (GO:0031032) | 5.94690629 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 5.80413011 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 5.77933977 |
| 21 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.76009083 |
| 22 | adult heart development (GO:0007512) | 5.71810282 |
| 23 | actin filament-based movement (GO:0030048) | 5.65516582 |
| 24 | * cardiac cell development (GO:0055006) | 5.63471758 |
| 25 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.60423151 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.56320271 |
| 27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.55585415 |
| 28 | tricarboxylic acid cycle (GO:0006099) | 5.54218005 |
| 29 | cardiac muscle hypertrophy (GO:0003300) | 5.49503132 |
| 30 | carnitine shuttle (GO:0006853) | 5.30563895 |
| 31 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.28596220 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.28192914 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.26710380 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.25297567 |
| 35 | muscle tissue morphogenesis (GO:0060415) | 5.25284196 |
| 36 | regulation of striated muscle contraction (GO:0006942) | 5.03350125 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 5.02215965 |
| 38 | regulation of sarcomere organization (GO:0060297) | 5.00785033 |
| 39 | skeletal muscle contraction (GO:0003009) | 4.95068673 |
| 40 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.93807939 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.87801369 |
| 42 | heart process (GO:0003015) | 4.76270248 |
| 43 | heart contraction (GO:0060047) | 4.76270248 |
| 44 | heart trabecula formation (GO:0060347) | 4.69721967 |
| 45 | muscle hypertrophy (GO:0014896) | 4.65910210 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.57101883 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.55027518 |
| 48 | fatty acid transmembrane transport (GO:1902001) | 4.52598987 |
| 49 | regulation of the force of heart contraction (GO:0002026) | 4.44810262 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.42557809 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 4.41384891 |
| 52 | muscle contraction (GO:0006936) | 4.12885283 |
| 53 | negative regulation of protein localization to cell surface (GO:2000009) | 4.07465046 |
| 54 | response to inactivity (GO:0014854) | 4.05482163 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.03244469 |
| 56 | regulation of coenzyme metabolic process (GO:0051196) | 4.03244469 |
| 57 | cardiac muscle cell action potential (GO:0086001) | 4.01866036 |
| 58 | muscle adaptation (GO:0043500) | 3.98964943 |
| 59 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.97016822 |
| 60 | cardiac chamber formation (GO:0003207) | 3.96035657 |
| 61 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.95560759 |
| 62 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.93622170 |
| 63 | creatine metabolic process (GO:0006600) | 3.92106643 |
| 64 | regulation of cardiac muscle contraction (GO:0055117) | 3.91632886 |
| 65 | cell communication by electrical coupling (GO:0010644) | 3.91372572 |
| 66 | carnitine transmembrane transport (GO:1902603) | 3.90262695 |
| 67 | skeletal muscle adaptation (GO:0043501) | 3.88543061 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86138548 |
| 69 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.85289826 |
| 70 | regulation of heart rate (GO:0002027) | 3.84185763 |
| 71 | * striated muscle cell development (GO:0055002) | 3.84126788 |
| 72 | muscle system process (GO:0003012) | 3.82156804 |
| 73 | negative regulation of potassium ion transport (GO:0043267) | 3.81933261 |
| 74 | cardiac muscle adaptation (GO:0014887) | 3.77907550 |
| 75 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.77907550 |
| 76 | muscle hypertrophy in response to stress (GO:0003299) | 3.77907550 |
| 77 | regulation of ATPase activity (GO:0043462) | 3.77048396 |
| 78 | regulation of ATP catabolic process (GO:1903289) | 3.77048396 |
| 79 | striated muscle adaptation (GO:0014888) | 3.75009064 |
| 80 | cardiac ventricle formation (GO:0003211) | 3.72139921 |
| 81 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.69348643 |
| 82 | regulation of cardioblast differentiation (GO:0051890) | 3.67476772 |
| 83 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.65749558 |
| 84 | regulation of muscle system process (GO:0090257) | 3.61676181 |
| 85 | response to epinephrine (GO:0071871) | 3.59002067 |
| 86 | regulation of heart contraction (GO:0008016) | 3.54876631 |
| 87 | carnitine transport (GO:0015879) | 3.54847319 |
| 88 | amino-acid betaine transport (GO:0015838) | 3.54847319 |
| 89 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.52402143 |
| 90 | muscle fiber development (GO:0048747) | 3.50378889 |
| 91 | muscle cell cellular homeostasis (GO:0046716) | 3.49747263 |
| 92 | regulation of muscle contraction (GO:0006937) | 3.47190376 |
| 93 | response to caffeine (GO:0031000) | 3.46252782 |
| 94 | positive regulation of cation channel activity (GO:2001259) | 3.41960444 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.41700252 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.41700252 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.41166817 |
| 98 | NADH metabolic process (GO:0006734) | 3.40285312 |
| 99 | striated muscle atrophy (GO:0014891) | 3.39307550 |
| 100 | skeletal muscle tissue development (GO:0007519) | 3.35580461 |
| 101 | response to muscle activity (GO:0014850) | 3.33201399 |
| 102 | muscle cell fate commitment (GO:0042693) | 3.30816887 |
| 103 | cardiac conduction (GO:0061337) | 3.30251403 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 3.30113032 |
| 105 | skeletal muscle fiber development (GO:0048741) | 3.29400495 |
| 106 | * muscle cell development (GO:0055001) | 3.28843430 |
| 107 | cellular response to epinephrine stimulus (GO:0071872) | 3.28006134 |
| 108 | regulation of sulfur metabolic process (GO:0042762) | 3.27588729 |
| 109 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.26644988 |
| 110 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.25313429 |
| 111 | ATP synthesis coupled proton transport (GO:0015986) | 3.25313429 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25305647 |
| 113 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.24806634 |
| 114 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.24806634 |
| 115 | regulation of sequestering of triglyceride (GO:0010889) | 3.22341958 |
| 116 | positive regulation of heart rate (GO:0010460) | 3.21135316 |
| 117 | myotube cell development (GO:0014904) | 3.19740328 |
| 118 | regulation of myoblast differentiation (GO:0045661) | 3.17972324 |
| 119 | muscle atrophy (GO:0014889) | 3.15116370 |
| 120 | relaxation of muscle (GO:0090075) | 3.14688846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.91173662 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.71493518 |
| 3 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.07431665 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.07431665 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.76168636 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.46088949 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.42015399 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35972378 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.31116609 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.22307800 |
| 11 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.11456420 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79849917 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.57857483 |
| 14 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.28834728 |
| 15 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.13270250 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.11208882 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08510653 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07889548 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01608628 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.98124602 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94638435 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.93325048 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.81194019 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79034692 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76977087 |
| 26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.75055702 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.66946493 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66068472 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63186646 |
| 30 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.62870614 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47886479 |
| 32 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41463833 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37858920 |
| 34 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37008767 |
| 35 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.36399924 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31991195 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30283826 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29928956 |
| 39 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26947600 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26609200 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25674849 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25266476 |
| 43 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24779546 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24481954 |
| 45 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.24046414 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22862084 |
| 47 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.22766979 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21846398 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20683149 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20263283 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19084882 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17757833 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17312157 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16078093 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15719752 |
| 56 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.15298762 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15218649 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14914541 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12379000 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12206549 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11213508 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10647846 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09238771 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09096859 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08103462 |
| 66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07020278 |
| 67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06504279 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05135212 |
| 69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04765574 |
| 70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01183208 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00926481 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00676491 |
| 73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97911041 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97911041 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97442839 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97424843 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97075154 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96998482 |
| 79 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96847398 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96018613 |
| 81 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95000636 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94452678 |
| 83 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91006264 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 0.90712283 |
| 85 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89969619 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89911439 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89524380 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89524380 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89102962 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87407139 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86903823 |
| 92 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86862006 |
| 93 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85942605 |
| 94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85685660 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85632840 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85395734 |
| 97 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.84988962 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84785034 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84105224 |
| 100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83825536 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83365931 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83125836 |
| 103 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83086143 |
| 104 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82710736 |
| 105 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82521787 |
| 106 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81341574 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81221099 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.80087041 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80071287 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80015508 |
| 111 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79680690 |
| 112 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.79548692 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79300416 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78820747 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78803684 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78696716 |
| 117 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77897782 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77540308 |
| 119 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77366461 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77244734 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77147718 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.76766343 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76283809 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.76096601 |
| 125 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.74386950 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74357238 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.73796871 |
| 128 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.73673576 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70996498 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70682324 |
| 131 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.69757768 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69583001 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.69334085 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68527228 |
| 135 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68406062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.69426972 |
| 2 | MP0000751_myopathy | 5.58796655 |
| 3 | MP0003646_muscle_fatigue | 5.53573036 |
| 4 | MP0004084_abnormal_cardiac_muscle | 5.38346163 |
| 5 | MP0000749_muscle_degeneration | 4.62594167 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.44207643 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.31642152 |
| 8 | MP0005330_cardiomyopathy | 3.81521083 |
| 9 | * MP0004087_abnormal_muscle_fiber | 3.29642878 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.27625486 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.07350842 |
| 12 | MP0002106_abnormal_muscle_physiology | 2.95414048 |
| 13 | * MP0002972_abnormal_cardiac_muscle | 2.94260327 |
| 14 | * MP0005620_abnormal_muscle_contractility | 2.82390418 |
| 15 | MP0008775_abnormal_heart_ventricle | 2.71371599 |
| 16 | MP0002269_muscular_atrophy | 2.61289428 |
| 17 | MP0000747_muscle_weakness | 2.56608967 |
| 18 | * MP0010630_abnormal_cardiac_muscle | 2.51519203 |
| 19 | * MP0003137_abnormal_impulse_conducting | 2.48176961 |
| 20 | MP0004130_abnormal_muscle_cell | 2.45276179 |
| 21 | MP0005369_muscle_phenotype | 2.40025116 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.36697142 |
| 23 | * MP0005385_cardiovascular_system_phenoty | 2.35883271 |
| 24 | * MP0001544_abnormal_cardiovascular_syste | 2.35883271 |
| 25 | MP0004484_altered_response_of | 2.27199105 |
| 26 | MP0006138_congestive_heart_failure | 2.19772770 |
| 27 | MP0004510_myositis | 2.07670704 |
| 28 | MP0003828_pulmonary_edema | 2.00704492 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 2.00047640 |
| 30 | MP0004085_abnormal_heartbeat | 1.90289726 |
| 31 | MP0004233_abnormal_muscle_weight | 1.87011996 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.84477890 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.56375161 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.43024387 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.37210313 |
| 36 | * MP0002127_abnormal_cardiovascular_syste | 1.29227659 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26618323 |
| 38 | MP0005670_abnormal_white_adipose | 1.19448879 |
| 39 | MP0000733_abnormal_muscle_development | 1.13969614 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.10659168 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.09214791 |
| 42 | * MP0000266_abnormal_heart_morphology | 1.09079493 |
| 43 | MP0000343_altered_response_to | 1.05355030 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.05059494 |
| 45 | MP0003279_aneurysm | 1.04178480 |
| 46 | MP0010368_abnormal_lymphatic_system | 0.97327900 |
| 47 | MP0005375_adipose_tissue_phenotype | 0.96546942 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 0.95412889 |
| 49 | MP0001661_extended_life_span | 0.89603964 |
| 50 | MP0005165_increased_susceptibility_to | 0.88965005 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.86644294 |
| 52 | MP0003566_abnormal_cell_adhesion | 0.84180029 |
| 53 | MP0005451_abnormal_body_composition | 0.79668236 |
| 54 | MP0002128_abnormal_blood_circulation | 0.79105415 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.77869763 |
| 56 | MP0005266_abnormal_metabolism | 0.77760110 |
| 57 | MP0005275_abnormal_skin_tensile | 0.74645196 |
| 58 | MP0000230_abnormal_systemic_arterial | 0.67535063 |
| 59 | MP0000013_abnormal_adipose_tissue | 0.67366154 |
| 60 | MP0002971_abnormal_brown_adipose | 0.67023130 |
| 61 | MP0008004_abnormal_stomach_pH | 0.63681423 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 0.63162894 |
| 63 | MP0000767_abnormal_smooth_muscle | 0.62681613 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 0.60246064 |
| 65 | MP0004270_analgesia | 0.59909507 |
| 66 | MP0000003_abnormal_adipose_tissue | 0.57487170 |
| 67 | MP0004272_abnormal_basement_membrane | 0.56145549 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 0.55985722 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.51496884 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.49479169 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.46851888 |
| 72 | MP0003303_peritoneal_inflammation | 0.45985555 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 0.43840542 |
| 74 | MP0003045_fibrosis | 0.41950285 |
| 75 | MP0009840_abnormal_foam_cell | 0.40965899 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.40749585 |
| 77 | MP0001784_abnormal_fluid_regulation | 0.39924117 |
| 78 | MP0005187_abnormal_penis_morphology | 0.39872330 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.39342778 |
| 80 | MP0004043_abnormal_pH_regulation | 0.38055833 |
| 81 | MP0001614_abnormal_blood_vessel | 0.36498902 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.35853079 |
| 83 | MP0003948_abnormal_gas_homeostasis | 0.34084393 |
| 84 | MP0003984_embryonic_growth_retardation | 0.33868443 |
| 85 | MP0000579_abnormal_nail_morphology | 0.33708032 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 0.33190938 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.32339590 |
| 88 | MP0008569_lethality_at_weaning | 0.31822903 |
| 89 | MP0004147_increased_porphyrin_level | 0.31815750 |
| 90 | MP0005166_decreased_susceptibility_to | 0.30492119 |
| 91 | MP0008874_decreased_physiological_sensi | 0.28703084 |
| 92 | MP0005334_abnormal_fat_pad | 0.28303590 |
| 93 | MP0003879_abnormal_hair_cell | 0.27216208 |
| 94 | MP0003941_abnormal_skin_development | 0.25542693 |
| 95 | MP0005595_abnormal_vascular_smooth | 0.23915708 |
| 96 | MP0009672_abnormal_birth_weight | 0.23784831 |
| 97 | MP0003091_abnormal_cell_migration | 0.23468301 |
| 98 | MP0000762_abnormal_tongue_morphology | 0.23413050 |
| 99 | MP0009115_abnormal_fat_cell | 0.21954372 |
| 100 | MP0005535_abnormal_body_temperature | 0.21882278 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.21753829 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.19288838 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.19025931 |
| 104 | MP0005452_abnormal_adipose_tissue | 0.18901164 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.18773197 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.18225241 |
| 107 | MP0001958_emphysema | 0.18008358 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.17364207 |
| 109 | MP0003075_altered_response_to | 0.17218513 |
| 110 | MP0000249_abnormal_blood_vessel | 0.16802503 |
| 111 | MP0005083_abnormal_biliary_tract | 0.16471747 |
| 112 | MP0004924_abnormal_behavior | 0.16438880 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.15821926 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.15309753 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.14706064 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.13921948 |
| 117 | MP0002970_abnormal_white_adipose | 0.13869276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.91726583 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.70594337 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.64754624 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.45420337 |
| 5 | Muscle fiber splitting (HP:0003555) | 6.42877689 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.33813068 |
| 7 | Ventricular tachycardia (HP:0004756) | 6.20670234 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.71777832 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.55932651 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.38942806 |
| 11 | Subaortic stenosis (HP:0001682) | 5.38942806 |
| 12 | Atrial fibrillation (HP:0005110) | 5.30475430 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.96925660 |
| 14 | Lipoatrophy (HP:0100578) | 4.95695908 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.95613934 |
| 16 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.92523168 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.86596907 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 4.80477030 |
| 19 | Supraventricular tachycardia (HP:0004755) | 4.78998870 |
| 20 | Myoglobinuria (HP:0002913) | 4.77778705 |
| 21 | Type 1 muscle fiber predominance (HP:0003803) | 4.77675480 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 4.70098835 |
| 23 | Increased connective tissue (HP:0009025) | 4.42920331 |
| 24 | Syncope (HP:0001279) | 4.29161564 |
| 25 | Difficulty running (HP:0009046) | 4.19836500 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 4.17287858 |
| 27 | Nemaline bodies (HP:0003798) | 4.13906838 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 4.03272691 |
| 29 | Prolonged QT interval (HP:0001657) | 3.96964664 |
| 30 | Bundle branch block (HP:0011710) | 3.91651038 |
| 31 | Palpitations (HP:0001962) | 3.79256697 |
| 32 | Ventricular arrhythmia (HP:0004308) | 3.77939839 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.74862295 |
| 34 | Myotonia (HP:0002486) | 3.67646565 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.44902235 |
| 36 | Heart block (HP:0012722) | 3.34602554 |
| 37 | Atrioventricular block (HP:0001678) | 3.26994482 |
| 38 | Ventricular fibrillation (HP:0001663) | 3.23786481 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 3.18451121 |
| 40 | Neck muscle weakness (HP:0000467) | 3.17907882 |
| 41 | Distal arthrogryposis (HP:0005684) | 3.11607650 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99090331 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.98033344 |
| 44 | Round ear (HP:0100830) | 2.90370379 |
| 45 | Muscle stiffness (HP:0003552) | 2.88265440 |
| 46 | Abnormal EKG (HP:0003115) | 2.84433542 |
| 47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.78509452 |
| 48 | Areflexia of lower limbs (HP:0002522) | 2.76273880 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.70532254 |
| 50 | Myopathic facies (HP:0002058) | 2.68456858 |
| 51 | Rimmed vacuoles (HP:0003805) | 2.60160492 |
| 52 | Left ventricular hypertrophy (HP:0001712) | 2.58135146 |
| 53 | Palmoplantar keratoderma (HP:0000982) | 2.53621037 |
| 54 | Absent phalangeal crease (HP:0006109) | 2.50253207 |
| 55 | EMG: neuropathic changes (HP:0003445) | 2.46773051 |
| 56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46573664 |
| 57 | Limb-girdle muscle atrophy (HP:0003797) | 2.46052871 |
| 58 | Deformed tarsal bones (HP:0008119) | 2.37164262 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.36531628 |
| 60 | Generalized muscle weakness (HP:0003324) | 2.35657227 |
| 61 | Gowers sign (HP:0003391) | 2.35263903 |
| 62 | Scapular winging (HP:0003691) | 2.30183169 |
| 63 | Testicular atrophy (HP:0000029) | 2.28348073 |
| 64 | Muscular dystrophy (HP:0003560) | 2.26065360 |
| 65 | Ulnar deviation of the wrist (HP:0003049) | 2.23964188 |
| 66 | Abnormality of the foot musculature (HP:0001436) | 2.19661500 |
| 67 | Hypoplastic ischia (HP:0003175) | 2.19299189 |
| 68 | Ketoacidosis (HP:0001993) | 2.15832446 |
| 69 | Weak cry (HP:0001612) | 2.15773060 |
| 70 | Facial diplegia (HP:0001349) | 2.15122697 |
| 71 | Hepatic necrosis (HP:0002605) | 2.14136161 |
| 72 | Ragged-red muscle fibers (HP:0003200) | 2.08331372 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.07244445 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.06440462 |
| 75 | Frequent falls (HP:0002359) | 2.05958587 |
| 76 | Conjunctival hamartoma (HP:0100780) | 2.03694361 |
| 77 | Hip contracture (HP:0003273) | 2.02873088 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 2.02450253 |
| 79 | Foot dorsiflexor weakness (HP:0009027) | 2.02348578 |
| 80 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01282529 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 2.01185495 |
| 82 | Sudden cardiac death (HP:0001645) | 1.95347053 |
| 83 | Waddling gait (HP:0002515) | 1.94888216 |
| 84 | Steppage gait (HP:0003376) | 1.94245418 |
| 85 | Hypoglycemic coma (HP:0001325) | 1.94105590 |
| 86 | Fatigable weakness (HP:0003473) | 1.90727660 |
| 87 | Abnormality of the neuromuscular junction (HP:0003398) | 1.90727660 |
| 88 | Abnormality of the ischium (HP:0003174) | 1.90255319 |
| 89 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.89648024 |
| 90 | Progressive muscle weakness (HP:0003323) | 1.89192152 |
| 91 | Proximal amyotrophy (HP:0007126) | 1.87013280 |
| 92 | Increased muscle lipid content (HP:0009058) | 1.86337601 |
| 93 | Hepatocellular necrosis (HP:0001404) | 1.84985542 |
| 94 | Congestive heart failure (HP:0001635) | 1.84794910 |
| 95 | Spinal rigidity (HP:0003306) | 1.84130822 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.82065964 |
| 97 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78935836 |
| 98 | Exercise intolerance (HP:0003546) | 1.77153590 |
| 99 | Bulbar palsy (HP:0001283) | 1.76261838 |
| 100 | Calcaneovalgus deformity (HP:0001848) | 1.75999141 |
| 101 | Hypoplastic heart (HP:0001961) | 1.75460441 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 1.71286269 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71286269 |
| 104 | Acute encephalopathy (HP:0006846) | 1.71045098 |
| 105 | Limb-girdle muscle weakness (HP:0003325) | 1.70431074 |
| 106 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70165131 |
| 107 | Dysmetric saccades (HP:0000641) | 1.68267544 |
| 108 | Malignant hyperthermia (HP:0002047) | 1.67518102 |
| 109 | Congenital malformation of the right heart (HP:0011723) | 1.66885606 |
| 110 | Double outlet right ventricle (HP:0001719) | 1.66885606 |
| 111 | Abnormality of the tricuspid valve (HP:0001702) | 1.61939917 |
| 112 | Aplasia of the musculature (HP:0100854) | 1.59658546 |
| 113 | Slender build (HP:0001533) | 1.55252919 |
| 114 | Type 2 muscle fiber atrophy (HP:0003554) | 1.52470719 |
| 115 | Hyperkalemia (HP:0002153) | 1.52228076 |
| 116 | Popliteal pterygium (HP:0009756) | 1.51649886 |
| 117 | Limited hip movement (HP:0008800) | 1.46811552 |
| 118 | Hypoplastic left heart (HP:0004383) | 1.46683768 |
| 119 | Diaphragmatic weakness (HP:0009113) | 1.46255408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.75114150 |
| 2 | TTN | 5.72945360 |
| 3 | PHKG1 | 4.22926314 |
| 4 | PHKG2 | 4.22926314 |
| 5 | DMPK | 3.26452931 |
| 6 | MYLK | 3.22998559 |
| 7 | LMTK2 | 2.95512762 |
| 8 | MUSK | 2.90592038 |
| 9 | PDK3 | 2.83416061 |
| 10 | PDK4 | 2.83416061 |
| 11 | PKN2 | 2.76457399 |
| 12 | TRIB3 | 2.73593827 |
| 13 | PIK3CA | 2.28399889 |
| 14 | NEK1 | 2.09989203 |
| 15 | BCKDK | 1.98229337 |
| 16 | STK24 | 1.83038197 |
| 17 | PINK1 | 1.71711296 |
| 18 | TIE1 | 1.67006266 |
| 19 | PDK2 | 1.66753930 |
| 20 | ZAK | 1.54846287 |
| 21 | PIK3CG | 1.47695403 |
| 22 | LIMK1 | 1.36753899 |
| 23 | MAP3K7 | 1.31990646 |
| 24 | MARK1 | 1.28469931 |
| 25 | ILK | 1.27728147 |
| 26 | MAP2K3 | 1.20942564 |
| 27 | NME1 | 1.19151440 |
| 28 | MAPK12 | 1.17979427 |
| 29 | MOS | 1.16472672 |
| 30 | PRKD1 | 1.15101353 |
| 31 | CAMK2D | 1.12151669 |
| 32 | PAK3 | 1.09082687 |
| 33 | MAPKAPK3 | 1.07552901 |
| 34 | ROCK1 | 1.00367148 |
| 35 | INSRR | 0.97495518 |
| 36 | CDC42BPA | 0.94067420 |
| 37 | RIPK1 | 0.93023721 |
| 38 | GRK7 | 0.91548227 |
| 39 | MAP3K3 | 0.91283979 |
| 40 | TRPM7 | 0.91035755 |
| 41 | MAP3K5 | 0.90430504 |
| 42 | PRKAA1 | 0.87099394 |
| 43 | PRKAA2 | 0.85292611 |
| 44 | STK38L | 0.82778902 |
| 45 | EPHB1 | 0.78860534 |
| 46 | PKN1 | 0.77373633 |
| 47 | MAPK4 | 0.76021203 |
| 48 | STK4 | 0.72715313 |
| 49 | PDGFRA | 0.69889673 |
| 50 | FLT3 | 0.69552562 |
| 51 | MAP3K6 | 0.69472347 |
| 52 | TAOK2 | 0.68260737 |
| 53 | WNK4 | 0.67540901 |
| 54 | DAPK3 | 0.67447704 |
| 55 | CCNB1 | 0.65640324 |
| 56 | SIK1 | 0.62878584 |
| 57 | ROCK2 | 0.57456789 |
| 58 | EEF2K | 0.54837816 |
| 59 | STK38 | 0.53963916 |
| 60 | AKT2 | 0.53761404 |
| 61 | CAMK2B | 0.52669318 |
| 62 | CAMK4 | 0.52090248 |
| 63 | PTK2B | 0.51745221 |
| 64 | DDR2 | 0.51086980 |
| 65 | TBK1 | 0.49408700 |
| 66 | MAP2K1 | 0.49323109 |
| 67 | TGFBR2 | 0.47232425 |
| 68 | PRKACB | 0.47130867 |
| 69 | CAMK2A | 0.46502953 |
| 70 | ICK | 0.45440223 |
| 71 | PRPF4B | 0.45177016 |
| 72 | WNK1 | 0.44553156 |
| 73 | RPS6KC1 | 0.44287998 |
| 74 | RPS6KL1 | 0.44287998 |
| 75 | BLK | 0.43748605 |
| 76 | CAMK1 | 0.39790568 |
| 77 | PTK6 | 0.39353526 |
| 78 | NEK9 | 0.39080079 |
| 79 | KDR | 0.38485590 |
| 80 | DYRK1B | 0.37779087 |
| 81 | CAMK2G | 0.37570398 |
| 82 | RPS6KA6 | 0.36756077 |
| 83 | ZAP70 | 0.36706247 |
| 84 | PRKACA | 0.36260445 |
| 85 | KSR2 | 0.35449080 |
| 86 | LATS1 | 0.34495808 |
| 87 | MAP3K10 | 0.32783347 |
| 88 | PRKACG | 0.31065701 |
| 89 | PDPK1 | 0.29297751 |
| 90 | MAP2K4 | 0.28949262 |
| 91 | PRKCE | 0.28545460 |
| 92 | MTOR | 0.28092376 |
| 93 | NLK | 0.27244715 |
| 94 | EPHB2 | 0.26712947 |
| 95 | IRAK3 | 0.26396213 |
| 96 | SGK2 | 0.26235063 |
| 97 | PRKG1 | 0.25941589 |
| 98 | FER | 0.25401080 |
| 99 | LATS2 | 0.24894242 |
| 100 | MAP2K6 | 0.24416441 |
| 101 | ERBB3 | 0.24396714 |
| 102 | MAPK11 | 0.24079858 |
| 103 | TAOK1 | 0.23883243 |
| 104 | MAP3K13 | 0.22734533 |
| 105 | MARK3 | 0.22332455 |
| 106 | RPS6KA1 | 0.21756551 |
| 107 | PDK1 | 0.21067060 |
| 108 | FGFR3 | 0.20764978 |
| 109 | MARK2 | 0.20625897 |
| 110 | PRKCH | 0.19362430 |
| 111 | MAPK10 | 0.18491246 |
| 112 | RPS6KA3 | 0.17199697 |
| 113 | STK11 | 0.16983982 |
| 114 | FGFR4 | 0.16587304 |
| 115 | SGK1 | 0.16568350 |
| 116 | MAPK7 | 0.16276483 |
| 117 | JAK1 | 0.15794099 |
| 118 | PRKD3 | 0.15449945 |
| 119 | STK39 | 0.15165916 |
| 120 | RET | 0.14821663 |
| 121 | SGK3 | 0.13945175 |
| 122 | RPS6KA2 | 0.13323637 |
| 123 | MAP3K11 | 0.12969040 |
| 124 | MAP3K1 | 0.12634459 |
| 125 | PRKG2 | 0.12056021 |
| 126 | PDGFRB | 0.11736752 |
| 127 | EPHA3 | 0.11486741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.45743194 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.53932030 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.36104510 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.30417290 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.08081051 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16044214 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.05475267 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.86420863 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.70397702 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56160105 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.55236760 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.34134722 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.05105243 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.98997092 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.98950107 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90529086 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90356949 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89158169 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61865640 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.59772231 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36441461 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34694589 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.31575925 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27588813 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.26768510 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17617288 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15324393 |
| 28 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.15201916 |
| 29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.13824310 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.10935062 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04321568 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01131484 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 0.95406023 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91378530 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89647112 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.89284485 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 0.87888868 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87049146 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.79818909 |
| 40 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79190588 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77585802 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77509726 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76243378 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74887420 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73532921 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73072747 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69682623 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66337452 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62750796 |
| 50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61866830 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61492266 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58389080 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55448768 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54295123 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53595625 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.53162535 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52974564 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52001367 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51984408 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.51685642 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51475170 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48535307 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.47208732 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.46028157 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.45493668 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43106830 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.43100791 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41423412 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39373522 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35841166 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34159825 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33122215 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.32996508 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32653852 |
| 75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32255602 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31859208 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28616003 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28356914 |
| 79 | Malaria_Homo sapiens_hsa05144 | 0.28150895 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.27571467 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24134503 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23618641 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.23261685 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22467720 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.20493733 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17794047 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16485316 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16033313 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.15113154 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.14157907 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14108427 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.14020454 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.12965138 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.12823942 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12729621 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.12599814 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.12419341 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.12186403 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.11792652 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.11555552 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11535333 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.11316158 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11202925 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.10913456 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.10564741 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10053320 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.09941746 |
| 108 | Gap junction_Homo sapiens_hsa04540 | 0.09761986 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.09691006 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09368069 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09231638 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.07901139 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07111932 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06837887 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.04836137 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.02158937 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0054959 |

